Archived News |

November 12, 2012

不良研究所 pharmacy professor invited to India to present breast cancer research

Renowned cancer researcher and Pfizer endowed professor of pharmacology at the University of Louisiana at Monroe Paul Sylvester will present his findings at three upcoming medical symposiums in India.

Sylvester, Ph.D., the director of graduate studies and research in the college of pharmacy, will present "Latest Findings: Research and Role of Tocotrienols in Cardiovascular and Metabolic Diseases,鈥� Nov. 24 in Mumbai and Nov. 25 in Chennai.

In January, he will travel to Annamalai University, located in Tamil Nadu, where he will present 鈥淭ocotrienols: a rare form of vitamin E that displays potent anticancer activity鈥� at the International conference on Phytochemicals in Health and Disease.

The U.S. Patent and Trademark Office recently awarded Sylvester and his colleagues from 不良研究所鈥檚 College of Pharmacy another patent for potentially life-saving anticancer research.

Sylvester, who collaborated with 不良研究所 pharmacy professors Khalid El Sayed, Ph.D., Amal Khalil Kaddoumi, Ph.D., and Sami Nazzal, Ph.D., said the compounds and methods in the patent have the potential to save and/or prolong lives through anticancer treatments.

The prospective uses of these newly discovered anticancer agents are significant within the field of cancer research, he said.

鈥淭he patent is for new and potent anticancer agents that were developed by creating carbamate ester analogues of natural tocotrienols鈥攁 natural, but rare form of vitamin E,鈥� said Sylvester. 鈥淪pecifically, these compounds show significant potential for use in the treatment of breast cancer.鈥�

PLEASE NOTE: Some links and e-mail addresses in these archived news stories may no longer work, and some content may include events which are no longer relevent, or reference individuals and/or organizations no longer associated with 不良研究所.